1,0
20 ago 2012
Dipendente attuale, più di 5 anni
Cambridge, MA
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
The science is interesting, the diseases being researched are in need of dedicated teams to create solutions, and the people who are left (after the acquisition by Sanofi) are really super.
Svantaggi
That being said, those people are leaving in droves, and the new parent company is totally focused on the bottom line, not what makes sense for patients, and certainly not what makes sense for the employees. There is no recognition by Sanofi that Genzyme employees made Genzyme what it was, and the loss of talent in the past several months is staggering!